Announcing the initial lineup of speakers for the 2016 Symposium!

No Comments

The 65th Annual Symposium of the New Orleans Academy of Ophthalmology will take place February 19th – 21st, 2016 at the Sheraton New Orleans Hotel. Our program committee is working hard to bring in the best and the brightest ophthalmologists from around the country to update our attendees on Glaucoma, Neuro-Ophthalmology and Cataract.

Four speakers are already confirmed! Look forward to learning from the following experts:

Paul F. Palmberg, M.D., Ph.D.
Bascom Palmer Eye Institute
Miami, FL

Louis R. Pasquale, M.D.
Massachusetts Eye and Ear
Boston, MA

Michael Wall, M.D.
University of Iowa
Iowa City, IA

Robert J. Weinstock, M.D.
Eye Institute of West Florida
Largo, FL

We are honored and excited to have such esteemed ophthalmologists as our faculty for the 2016 meeting! Subscribe to our emails or follow us via the social media buttons to the left for all the latest news about our upcoming symposium.

For the last 65 years, the New Orleans Academy of Ophthalmology (NOAO) puts on an annual meeting which offers hours in Category 1 credit towards the AMA Physician’s Recognition Award™. NOAO is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.

Member feedback greatly aids the formation of this world class educational meeting. If you have any suggestions for topics and/or speakers, please contact us as soon as possible.

Registration is now open!

Register Now


Speakers

Paul Palmberg MD

Paul F. Palmberg, M.D., Ph.D., now a Professor of Ophthalmology at Bascom Palmer Eye Institute, knew early on that he wanted to follow in his father’s footsteps and become an ophthalmologist. At age 19, he decided that he also wanted to be a scientist. “I wanted to find out if being ‘dual-wired’ would let me see connections between science and medicine that scientists or clinicians were unlikely to come up with independently,” he recalls.

In 1978, he introduced Modified MK Media, an improved solution for maintaining corneas for transplantation which was adopted worldwide. In the 1980s, his discoveries of simplified methods for detecting early diabetic retinopathy led to a decade-long trial by the National Institutes of Health which concluded that tightly controlling blood sugar significantly lowered the risk of retinal and kidney damage in diabetic patients.

Dr. Palmberg is best known, however, for his role in helping to clarify the relationship between the level of pressure in the eye and how well a glaucoma patient retains peripheral vision. In 2000, Palmberg was co-recipient of the International Glaucoma Review Award for the most significant glaucoma research of the year for his finding that lowering eye pressure sufficiently could halt glaucoma damage in nearly all patients with advanced damage.

Dr. Palmberg has authored or co-authored 84 journal articles and book chapters, lectured in 55 countries, and trained 52 clinical fellows and 103 foreign observer fellows. Palmberg hopes in his last decade of practice to develop teaching modules in both English and foreign languages to explain the new concepts for treating glaucoma.

 

Louis Pasquale MDLouis R. Pasquale, M.D. is director of both the Glaucoma Service and the Ophthalmology Telemedicine program at Massachusetts Eye and Ear, where he specializes in glaucoma—a leading cause of blindness in the United States and throughout the world. He is especially interested in normal tension glaucoma, difficult surgical glaucoma, and secondary glaucoma in children. Dr. Pasquale also is a dedicated teacher and mentor. He trains residents and medical students and serves as the Director of Mass. Eye and Ear’s fellowship program.

Dr. Pasquale aims to eradicate functional blindness from primary open angle glaucoma (POAG) and exfoliation syndrome through early detection and an improved understanding of disease pathogenesis. In addition to his clinical practice, he is investigating how genes interact with the environment to cause glaucoma. He was awarded a grant as part of the National Institutes of Health’s Genes, Environment & Heath Initiative to rapidly scan the entire human genome in order to discover the genetic determinants of POAG. Dr. Pasquale is also involved in an initiative that integrates telemedicine technologies to improve access to ophthalmic services by allowing patients to receive ophthalmic consultations virtually.

Throughout his career, Dr. Pasquale has received numerous honors, including the HMS Department of Ophthalmology Distinguished Ophthalmology Scholar Award, the Secretariat Award from the American Academy of Ophthalmology, the Silver Fellow Award from the Association for Research in Vision and Ophthalmology (ARVO), and many others.

 

Wall~Michael

Michael Wall, M.D., a graduate of Tulane University School of Medicine in New Orleans, is Director of the Neuro-Ophthalmology Clinic and Professor of Neurology, Ophthalmology and Visual Sciences at the University of Iowa, where he weaves together his medical practice, teaching and research.

“What I really love are the interactions with seeing patients, teaching, and doing research,” he says. “They enhance each other in a way that makes every day interesting.”

Dr. Wall’s research has two arms. The first, funded by a VA Merit review for 12 years, is to develop strategies to detect visual field changes and defects at an earlier stage by studying mechanisms of perimetric variability. Dr. Wall and his colleagues are in the fourth year of a five year study that follows glaucoma patients with four visual field tests to determine if larger stimuli result in earlier detection of visual field change.

The second arm of Dr. Wall’s research is to study idiopathic intracranial hypertension (pseudotumor cerebri). The goal is to find the cause of the disease and to develop evidence-based treatment strategies. Currently all treatment decisions are based on data that is retrospective and uncontrolled. This clinical trial has been funded by the National Institutes of Health for $16 million over five years.

 

Robert Weinstock MDRobert J. Weinstock, M.D. is Director of Cataract and Refractive Services at the Eye Institute of West Florida and the Weinstock Laser Eye Center. He is also an associate clinical professor of ophthalmology at the University of South Florida and serves as the Surgical Director of the Largo Ambulatory Surgery Center.

A board-certified ophthalmologist fellowship-trained in cataract and refractive surgery, Dr. Weinstock became interested in ophthalmology at an early age as he watched and assisted his father. In addition to performing thousands of vision correcting cataract and LASIK procedures each year, Dr. Weinstock speaks and teaches nationally and internationally on customized cataract surgery and surgical innovations. He is continuously engaged in clinical research and studies to evaluate new technologies, many of which are sanctioned by the FDA.

Dr. Weinstock was one of 250 named in Premier Surgeon’s List of Leading Innovators of 2010 for his contributions to cataract surgery and premium IOLs. He is recognized internationally as an expert on new implant technology and a pioneer in micro incisional surgical techniques. He has authored many book chapters on cataract surgery and continues to write journal articles on cataract and refractive surgery.

 

 

Comments are closed.